Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1 1

Status

Not yet recruiting 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 92INDUSTRY 37NIH 20NETWORK 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 1

Conditions

Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 9Prostatic Neoplasms 8Colorectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Melanoma 7Burkitt Lymphoma 6Pancreatic Neoplasms 5Lung Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Acute 4Leukemia, Biphenotypic, Acute 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Wilms Tumor 3Osteosarcoma 3Malignant Solid Neoplasm 3Lymphoma, Non-Hodgkin 3Lymphoma 3Hematologic Neoplasms 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Teratoma 2Squamous Cell Carcinoma of Head and Neck 2Rhabdomyosarcoma, Embryonal 2Recurrence 2

Interventions

Specimen Handling 3Cytarabine 3revumenib 2merphos 2Methotrexate 2Hydrocortisone 2Biopsy 2gilteritinib 1asparaginase erwinia chrysanthemi recombinant 1X-Rays 1Stem Cell Transplantation 1Standard of Care 1Razoxane 1Practice Guidelines as Topic 1Mitoxantrone 1Magnetic Resonance Spectroscopy 1Liposomes 1Injections 1Gemtuzumab 1Fluorodeoxyglucose F18 1Etoposide 1Dexrazoxane 1Daunorubicin 1CPX-351 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Myeloid, Acute × 30 days × Clear all
NCT07022678 2026-05-22

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Children's Oncology Group

Phase 3 Not yet recruiting
556 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04293562 2026-05-05

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Children's Oncology Group

Phase 3 Recruiting
1,186 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07498465 2026-05-05

A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia

Children's Oncology Group

Phase 1 Withdrawn
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07563010 2026-05-04

Menin-Inhibitor Targeted Maintenance in AML

Center for International Blood and Marrow Transplant Research

Phase 2 Not yet recruiting
144 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡